Manufacturer record
Acro Lifesciences (India) Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Acro Lifesciences (India) Pvt. Ltd (Maharashtra) were declared Not of Standard Quality between November 2022 and December 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CG23Y1, CALCIUM GLUCONATE INJECTION I.P. 10ml (exp Apr 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay of Calcium Gluconate, Particulate Matter and Description. Listed in the December 2023 alert.
Records by type
2 records linked to Acro Lifesciences (India) Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| CALCIUM GLUCONATE INJECTION I.P. 10ml | Batch CG23Y1Mfg May 2023 · Exp Apr 2025 | Assay of Calcium Gluconate, Particulate Matter and Description.Assay | CDL KolkataCDSCO lab | Dec 2023 |
| Neostigmine Injection I.P. 0.5 mg /ml | Batch NM22L2Mfg Jul 2022 · Exp Jun 2024 | Description, Particulate Matter & AssayAssay | CDL KolkataCDSCO lab | Nov 2022 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.